Bio-Connect
WB analysis of extracts from mouse brain tissue using GTX50222 alpha Synuclein (phospho Ser129) antibody. Lane 1 : Primary antibody pre-incubated with the antigen specific peptide
WB analysis of extracts from mouse brain tissue using GTX50222 alpha Synuclein (phospho Ser129) antibody. Lane 1 : Primary antibody pre-incubated with the antigen specific peptide
WB analysis of extracts from mouse brain tissue using GTX50222 alpha Synuclein (phospho Ser129) antibody. Lane 1 : Primary antibody pre-incubated with the antigen specific peptide

alpha Synuclein (phospho Ser129) antibody

Research Use Only
GTX50222
GeneTex
ApplicationsImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
Product group Antibodies
ReactivityHuman, Mouse, Rat
TargetSNCA
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    alpha Synuclein (phospho Ser129) antibody
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 1:500-1:1000. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    ImmunoFluorescence, Western Blot, ImmunoCytoChemistry, ImmunoHistoChemistry
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    1 mg/ml
  • Conjugate
    Unconjugated
  • Formulation
    Liquid
  • Gene ID6622
  • Target name
    SNCA
  • Target description
    synuclein alpha
  • Target synonyms
    alpha-synuclein; I+/--synuclein; NACP; non A-beta component of AD amyloid; PARK1; PARK4; PD1; synuclein alpha-140; synuclein, alpha (non A4 component of amyloid precursor); truncated alpha synuclein
  • Host
    Rabbit
  • Isotype
    IgG
  • Modification Type
    Phosphorylated
  • Protein IDP37840
  • Protein Name
    Alpha-synuclein
  • Scientific Description
    Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimers disease. Alternatively spliced transcripts encoding different isoforms have been identified for this gene. [provided by RefSeq, Feb 2016]
  • Reactivity
    Human, Mouse, Rat
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • Striatal Afferent BDNF Is Disrupted by Synucleinopathy and Partially Restored by STN DBS. Miller KM et al., 2021 Mar 3, J Neurosci
    Read more
  • Intracellular delivery of Parkin rescues neurons from accumulation of damaged mitochondria and pathological alpha-synuclein. Chung E et al., 2020 May, Sci Adv
    Read more
  • LRRK2 inhibition prevents endolysosomal deficits seen in human Parkinsons disease. Rocha EM et al., 2020 Feb, Neurobiol Dis
    Read more
  • Microglia as modulators of exosomal alpha-synuclein transmission. Xia Y et al., 2019 Feb 20, Cell Death Dis
    Read more
  • Identification of a highly neurotoxic alpha-synuclein species inducing mitochondrial damage and mitophagy in Parkinsons disease. Grassi D et al., 2018 Mar 13, Proc Natl Acad Sci U S A
    Read more
  • Pleiotropic neuropathological and biochemical alterations associated with Myo5a mutation in a rat Model. Landrock KK et al., 2018 Jan 15, Brain Res
    Read more